Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:6_2
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 6 cl 2
Character Range: 18608732–18609671

2  Assessment of patient
  For the purposes of paragraph 1(b), the patient has been assessed in accordance with this clause if the treating practitioner has:
 (a) documented in the patient's medical records:
 (i) repeat test results showing the patient is antibody to hepatitis C virus (anti‑HCV) positive; and
 (ii) a test result showing the patient is hepatitis C virus ribonucleic acid (RNA) positive; and
 (iii) if known, evidence of the patient's hepatitis C virus genotype; and
 (b) chosen a treatment regimen listed for the patient in clause 3; and
 (c) collected the following information:
 (i) whether the patient is cirrhotic or non‑cirrhotic;
 (ii) details of the previous treatment regimen, if the patient has previously failed a treatment with a regimen containing an NS5A inhibitor and the chosen treatment regimen is treatment with:
 (A) sofosbuvir with velpatasvir and voxilaprevir; or
 (B) glecaprevir with pibrentasvir.